Navigation Links
InVitria to Present at WilBio's International Cell Engineering Meeting
Date:11/4/2008

Innovator of animal free and defined cell culture media components will feature its productivity maximizing product at WilBio Dec. 2-4, 2008.

Fort Collins, CO (PRWEB) November 4, 2008 -- InVitria's Cellastim (recombinant albumin), which has been shown to outperform animal derived albumins in cell culture, will be featured at the 2nd International Cell Engineering Meeting hosted by the Williamsburg BioProcessing Foundation (WilBio) on December 2-4 in Santa Barbara, CA (US).

InVitria's Director of Cell Culture, Dr. Steve Pettit, will present results from the recently completed study entitled, "Recombinant Human Serum Albumin Expressed in Plants Improves the Productivity and Growth Kinetics of CHO" at the 2008 WilBio meeting, which is centered on optimizing cell productivity, stability and safety.

Data from the study showed that Cellastim is a robust supplement for CHO media and can improve both the growth kinetics and productivity of CHO cell lines. Tests have shown that Cellastim outperforms plasma-derived human serum albumin and can result in an average 50% increase in productivity across a variety of chemically defined cell culture media.

"InVitria's Cellastim is a safe and effective alternative for improving cell culture performance," said InVitria President Scott Deeter. "WilBio's 2008 Cell Engineering Meeting will be focused on cell optimization, stability and safety--all of which are a good match for the benefits delivered by Cellastim in cell culture media."

About InVitria
InVitria has developed defined and animal free cell culture media components that enhance productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Cellastim is an animal free component used to enhance cell growth and productivity in cell culture media.

For more information about InVitria's products, please contact us by e-mail or phone.

E-mail: info@InVitria.com
Phone: 1-800-916-8311

###

Read the full story at http://www.prweb.com/releases/Cellastim/cellproductivity/prweb1570394.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Jennerex To Present at Rodman & Renshaw 10th Annual Healthcare Conference
2. Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12
3. Alexion to Present at Investor Conferences
4. IPC The Hospitalist Company, Inc. to Present at the 2008 Annual Credit Suisse Health Care Conference
5. Jazz Pharmaceuticals to Present at Investor Conferences
6. Senesco Technologies to Present at 10th Annual Rodman & Renshaw Healthcare Conference
7. XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11
8. The Quantum Group Inc. To Present at Paulson Investments 31st Annual Westergaard Conference
9. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
10. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
11. BD to Present at Investor Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... Opelousas, LA (PRWEB) , ... July 23, 2017 ... ... providers to interact, thus improving communication, safety and patient-provider relationships. New tools are ... according to results of the 19th Annual Health Care’s Most Wired® survey, released ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... Florida Pain Relief Group – Melbourne, a practice owned by Physician Partners of ... interventional pain management, Dr. Stern also is certified in pediatrics, emergency medicine and ...
(Date:7/23/2017)... ... ... Viora Ltd., a leading medical aesthetics solutions manufacturer, is ... United States Patent and Trademark Office. The patent applies to treatments with Viora’s ... mechanisms to further increase the efficacy and safety of final treatment results for ...
(Date:7/22/2017)... , ... July 22, 2017 , ... ... year with the majority of patients not requiring pain medication after three months ... Sports Medicine’s Annual Meeting today in Toronto, Ontario, Canada found that those ...
(Date:7/21/2017)... PITTSBURGH, PA (PRWEB) , ... July 21, 2017 , ... ... I use a lot of pleural catheters available on the market," said an inventor ... level of comfort and safety for the patient." , He developed the patent-pending PLEURAL ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  The global market for ... of approximately $394.1 million in 2016.  Although in early ... solid growth, in particular as a result of the ... and the recent introduction of a significant number of ... less-invasive testing of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing a ... who suffer from painful intercourse and other painful pelvic pain conditions such ... to menopause. ... LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a void ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment and ... 2021, according to Medical Equipment & Supplies: ... Freedonia Focus Reports. Continued increases in demand for medical ... of the population and supported by gains in disposable ... and supplies. New product introductions will also drive sales ...
Breaking Medicine Technology: